Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3HC3

BHA10 IgG1 Fab double mutant variant - antibody directed at human LTBR

3HC3 の概要
エントリーDOI10.2210/pdb3hc3/pdb
関連するPDBエントリー3HC0 3HC4
分子名称IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN, IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN, ACETATE ION, ... (5 entities in total)
機能のキーワードigg1 fab, bha10, immune system
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数2
化学式量合計46994.96
構造登録者
Arndt, J.W.,Jordan, J.L.,Lugovskoy, A.,Wang, D. (登録日: 2009-05-05, 公開日: 2009-08-04, 最終更新日: 2024-10-16)
主引用文献Jordan, J.L.,Arndt, J.W.,Hanf, K.,Li, G.,Hall, J.,Demarest, S.,Huang, F.,Wu, X.,Miller, B.,Glaser, S.,Fernandez, E.J.,Wang, D.,Lugovskoy, A.
Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules
Proteins, 77:832-841, 2009
Cited by
PubMed Abstract: Bispecific immunoglobulin-like antibodies capable of engaging multiple antigens represent a promising new class of therapeutic agents. Engineering of these molecules requires optimization of the molecular properties of one of the domain components. Here, we present a detailed crystallographic and computational characterization of the stabilization patterns in the lymphotoxin-beta receptor (LTbetaR) binding Fv domain of an anti-LTbetaR/anti-TNF-related apoptosis inducing ligand receptor-2 (TRAIL-R2) bispecific immunoglobulin-like antibody. We further describe a new hierarchical structure-guided approach toward engineering of antibody-like molecules to enhance their thermal and chemical stability.
PubMed: 19626705
DOI: 10.1002/prot.22502
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.72 Å)
構造検証レポート
Validation report summary of 3hc3
検証レポート(詳細版)ダウンロードをダウンロード

239492

件を2025-07-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon